Company profile - Brighter Actiste feature image - 16092019 - JPG



SEK966.1m market cap

SEK10.6 last close

Brighter is a Swedish healthtech company focused on the development and commercialisation of self-monitoring and self-treatment health solutions for diabetes.

Investment summary

After receiving two CE marks for the Actiste device, Brighter is registering the product with local authorities in the United Arab Emirates (UAE). On introduction to the market, it will conduct user experience pilot tests to optimise adoption. Following the UAE, the company plans to focus its commercialisation efforts on Sweden, the rest of the Gulf Cooperation Council (GCC) area and South-East Asia (particularly Thailand and Indonesia).

Y/E Dec
Revenue (SEKm)
EPS (öre)
P/E (x)
P/CF (x)
2017A 1.4 (19.7) (22.8) (40.00) N/A N/A
2018A 1.1 (44.2) (48.8) (74.00) N/A N/A
2019E 0.5 (52.9) (66.4) (80.81) N/A N/A
2020E 24.5 (63.8) (78.1) (82.93) N/A N/A
Industry outlook

In 2017, costs attributed to diagnosed diabetes and associated complications, such as cardiovascular disease and nephropathy, totalled $327bn in the US. Patient opinions of treatment burden are heavily correlated with adherence to self-care.

Last updated on 11/11/2019
Share price graph
Balance sheet
Forecast net cash (SEKm) 19.6
Forecast gearing ratio (%) N/A
Price performance
Actual 4.1 (0.6) 2.9
Relative* (1.6) (10.9) (11.9)
52-week high/low SEK14.1/SEK7.9
*% relative to local index
Key management
Truls Sjostedt CEO
Henrik Norström Chief Operating Officer
Petra Kaur Chief Marketing and Communications Officer